Read news on prostate cancer with our app.
Read more in the app
CRISPR makes prostate cancer vulnerable to immunotherapy
New Tool Supercharges Immunotherapy Against Prostate Cancer
DNA blood test improves patient selection for radiopharmaceutical therapy in prostate cancer - EurekAlert!
Researchers Uncover a Promising New Way To Stop Prostate Cancer From Spreading
Parsing the pathology of prostate cancer - EurekAlert!
Intratumoral androgens and genetic variants driving therapy resistance in prostate cancer - EurekAlert!
Study finds prostate cancer screening discussions are rare – but make a big difference - EurekAlert!
Perioperative apalutamide in high-risk localized or locally advanced prostate cancer reduces risk of metastasis and death - EurekAlert!
Largest study of prostate cancer in Brazil’s public health system reveals racial inequalities in diagnosis and treatment - EurekAlert!
Just two radiotherapy sessions given over eight days can treat prostate cancer without any extra side effects - EurekAlert!
PSMA therapy delays hormone therapy in prostate cancer - EurekAlert!
New Experimental Drug Shrinks Tumors in Prostate Cancer Clinical Trial
Scientists “turbocharge” immune cells to attack prostate cancer - EurekAlert!
Study identifies gene linked to chemotherapy resistance in prostate cancer - EurekAlert!
Scientists report landmark “evolutionary double-bind” strategy to overcome treatment resistance in prostate cancer - EurekAlert!
Half of all men over 60 have prostate cancer – an AI diagnostic tool could identify which need followup - EurekAlert!
Study shows strong evidence for effectiveness of metastasis-directed radiation therapy in prostate cancer - EurekAlert!
Small but abundant molecules impacting prostate cancer - EurekAlert!
Novel therapy using engineered immune cells to kill prostate cancer earns $1.8 million Department of Defense grant - EurekAlert!
Model predicts long term mortality risk from prostate cancer - EurekAlert!
